Atara Biotherapeutics, Inc. financial data

Symbol
ATRA on Nasdaq
Location
Thousand Oaks, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 63% % 8.8%
Quick Ratio 5% % -47%
Debt-to-equity -206% % 17%
Return On Equity -42% % -131%
Return On Assets 39% %
Operating Margin 17% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,210,235 shares 25%
Common Stock, Shares, Outstanding 7,210,000 shares 26%
Entity Public Float $41,039,683 USD -75%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 13,564,000 shares 82%
Weighted Average Number of Shares Outstanding, Diluted 13,564,000 shares 82%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $151,930,000 USD -91%
Research and Development Expense $66,389,000 USD -61%
General and Administrative Expense $31,416,000 USD -25%
Costs and Expenses $125,708,000 USD -46%
Operating Income (Loss) $26,222,000 USD 84%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $23,413,000 USD 81%
Income Tax Expense (Benefit) $12,000 USD -33%
Net Income (Loss) Attributable to Parent $23,401,000 USD 80%
Earnings Per Share, Basic 3 USD/shares 89%
Earnings Per Share, Diluted 3 USD/shares 89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,742,000 USD -88%
Accounts Receivable, after Allowance for Credit Loss, Current $1,913,000 USD 43%
Inventory, Net $0 USD -100%
Other Assets, Current $2,807,000 USD -70%
Assets, Current $18,432,000 USD -80%
Property, Plant and Equipment, Net $147,000 USD -91%
Operating Lease, Right-of-Use Asset $10,707,000 USD -77%
Other Assets, Noncurrent $881,000 USD -74%
Assets $30,167,000 USD -79%
Accounts Payable, Current $318,000 USD -85%
Employee-related Liabilities, Current $2,067,000 USD -73%
Accrued Liabilities, Current $2,552,000 USD -68%
Liabilities, Current $18,057,000 USD -88%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $15,005,000 USD -57%
Other Liabilities, Noncurrent $1,763,000 USD -56%
Liabilities $66,801,000 USD -71%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,000 USD -91%
Retained Earnings (Accumulated Deficit) $2,018,459,000 USD 1.1%
Stockholders' Equity Attributable to Parent $36,634,000 USD 60%
Liabilities and Equity $30,167,000 USD -79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $28,138,000 USD 5%
Net Cash Provided by (Used in) Financing Activities $250,000 USD -101%
Net Cash Provided by (Used in) Investing Activities $17,199,000 USD 17%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 7,210,000 shares 26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,742,000 USD -88%
Interest Paid, Excluding Capitalized Interest, Operating Activities $66,000 USD -42%
Deferred Tax Assets, Valuation Allowance $368,401,000 USD -22%
Deferred Tax Assets, Gross $377,148,000 USD -22%
Operating Lease, Liability $16,958,000 USD
Depreciation $300,000 USD -92%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $23,381,000 USD 80%
Lessee, Operating Lease, Liability, to be Paid $23,278,000 USD
Property, Plant and Equipment, Gross $551,000 USD -97%
Operating Lease, Liability, Current $1,953,000 USD -86%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,258,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $1,017,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -18%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,320,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,226,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $259,376,000 USD -20%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $37,933,000 USD -76%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,319,000 USD
Operating Lease, Payments $4,139,000 USD 3.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $8,747,000 USD -25%
Share-based Payment Arrangement, Expense $14,081,000 USD -55%
Interest Expense $3,915,000 USD -18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%